ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
3 explosive ASX growth shares to buy in March
52-Week Highs
Why these ASX shares just surged to 52-week highs
Share Market News
Where I'd invest $10,000 in a volatile 2020
Growth Shares
3 excellent ASX healthcare shares to bring your portfolio to life
Growth Shares
Why I would buy Xero and these ASX growth shares
Share Market News
Top brokers name 3 ASX shares to buy next week
Share Market News
Leading brokers name 3 ASX shares to sell today
⏸️ ASX Shares
Is the ResMed share price in the buy zone?
Share Market News
3 ASX shares I'd buy in today's falling market
Share Market News
Leading brokers name 3 ASX shares to buy today
Share Gainers
Why the ResMed share price stormed 14% higher in January
Share Market News
Fisher & Paykel Healthcare share price on watch after new product launch
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
